Selective Agonists of Thyroid Hormone Receptor Beta: Promising Tools for the Treatment of Nonalcoholic Fatty Liver Disease
Endocrinology and Metabolism · 30.04.2024 · 39 (2) · 285-287
DOI: 10.3803/enm.2024.203 ↗Kurz gefasst
Editorial in der Zeitschrift Endocrinology and Metabolism, erschienen am 30.04.2024. Verfasst von Sun Wook Cho. Beteiligte Einrichtung: Department of Internal Medicine, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea. Hauptthemen laut MEDLINE: Non-alcoholic Fatty Liver Disease, Thyroid Hormone Receptors beta. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Thyroid hormone receptor beta (THR-β) is the primary isoform of the THR found in the liver, and it is primarily responsible for reducing cholesterol levels. Conversely, THR-α is predominant - ly associated with adverse effects on the heart and bones. Therefore, significant efforts have been made to develop drug candidates with isomer-specific activity, targeting the structure of thyroid hormones to create thyromimetics that selectively target THR-β for application in liver disease [1]
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea.
Zitieren
APA
Cho, S. W. (2024). Selective Agonists of Thyroid Hormone Receptor Beta: Promising Tools for the Treatment of Nonalcoholic Fatty Liver Disease. Endocrinology and Metabolism, 39(2), 285-287. https://doi.org/10.3803/enm.2024.203
Vancouver
Cho SW. Selective Agonists of Thyroid Hormone Receptor Beta: Promising Tools for the Treatment of Nonalcoholic Fatty Liver Disease. Endocrinology and Metabolism. 2024;39(2):285-287. doi:10.3803/enm.2024.203
BibTeX
@article{Cho2024,
author = {Cho, Sun Wook},
title = {Selective Agonists of Thyroid Hormone Receptor Beta: Promising Tools for the Treatment of Nonalcoholic Fatty Liver Disease},
journal = {Endocrinology and Metabolism},
year = {2024},
volume = {39},
number = {2},
pages = {285--287},
doi = {10.3803/enm.2024.203}
}
EUVIMED